Cortagen 50mg

What is Cortagen (50mg)?

Cortagen is a short synthetic regulatory peptide composed of four amino acids (Ala-Glu-Asp-Pro). It is classified as a bioregulatory tetrapeptide originally derived from studies of cortical tissue extracts. In laboratory settings, Cortagen has been studied for its potential effects on neuronal cell cultures, gene expression modulation, and age-related biological processes. It is being researched in experimental models focusing on neuroregulatory signaling and cellular adaptation mechanisms.

What are the key features of Cortagen (50mg)?

Cortagen (50mg) is provided as a lyophilized powder for laboratory reconstitution and controlled experimental applications. It is commonly used in research environments focused on peptide signaling and cellular biology.

• Sequence: Ala-Glu-Asp-Pro
• Molecular Weight: 430.17 g/mol
• Chemical Formula: C₁₇H₂₇N₅O₈
• High purity (≥98%), confirmed by analytical testing
• Supplied as lyophilized powder in sealed vial
• Studied in neurobiological and gene expression research
• Suitable for controlled in-vitro and preclinical laboratory models
• For laboratory research use only

How is Cortagen (50mg) synthesized?

Cortagen is synthesized using solid-phase peptide synthesis (SPPS), allowing precise assembly of its four-amino-acid sequence. This ensures structural consistency and reproducibility across production batches. After synthesis, the peptide is purified using high-performance liquid chromatography (HPLC) to meet high-purity standards. Structural confirmation and molecular weight verification are conducted using mass spectrometry (MS). These analytical methods ensure batch validation and confirm that the final product meets research-grade specifications.

What is Cortagen (50mg) being studied for? What are its possible benefits?

Published research has explored Cortagen in experimental models, including neuronal cell cultures and aging biology. Studies have examined its potential influence on gene expression regulation, particularly in cortical and neural tissues. Some investigations suggest that the peptide may interact with DNA transcription processes in laboratory conditions. Cortagen is also being studied in models examining cellular stress adaptation and age-associated changes in tissue function. Reported research has explored its role in modulating protein synthesis pathways and maintaining cellular homeostasis. These findings are still under investigation and do not establish therapeutic or clinical effects.

How does Cortagen (50mg) work in research studies?

In laboratory investigations, Cortagen is thought to function as a short regulatory peptide that influences intracellular signaling pathways. Experimental data suggest that it may interact with chromatin structures and affect transcriptional activity in certain cell types. Preclinical studies propose that Cortagen may modulate the expression of genes involved in cellular maintenance and metabolic regulation. In neuronal cell models, it has been examined for its potential effects on differentiation and survival under controlled conditions. These mechanisms are still under active scientific investigation.

What dosing information exists for Cortagen (50mg)?

Published preclinical studies have evaluated Cortagen at varying concentrations depending on the experimental design. In in-vitro research, peptide concentrations have been tested in the microgram per milliliter (µg/mL) range to assess cellular responses. In animal studies, dosing regimens have varied and were administered under controlled laboratory conditions. Specific reported doses are expressed in micrograms per kilogram (µg/kg). There are no standardized human dosing guidelines, as Cortagen is not approved for clinical use and remains limited to laboratory investigation.

How should Cortagen (50mg) be stored and handled?

Cortagen (50mg) should be stored in its lyophilized form at –20 °C, protected from light and moisture to maintain stability. Under proper storage conditions, peptide integrity is preserved for extended laboratory use. After reconstitution with a sterile laboratory-grade solvent, the solution should be stored at 2–8 °C and used within a defined timeframe to minimize degradation. Repeated freeze-thaw cycles should be avoided, as these may affect structural stability. Proper sterile handling techniques are recommended during preparation and aliquoting.

Where can I read more research about Cortagen (50mg)?

Researchers seeking additional information may consult peer-reviewed publications indexed in scientific databases. Relevant studies examining Cortagen and related bioregulatory peptides include:

1. Anisimov SV, Khavinson VKh, Anisimov VN. Elucidation of the effect of brain cortex tetrapeptide Cortagen on gene expression in mouse heart by microarray. Neuro Endocrinol Lett. 2004;25(1-2):87-93.
2. Khavinson VKh, Malinin VV, Chalisova NI, Grigor'ev EI. Tkanespetsificheskoe deĭstvie peptidov v kul'ture tkaneĭ krys raznogo vozrasta [Tissue-specific action of peptides in tissue culture of rats of various ages]. Adv Gerontol. 2002;9:95-100.
3. Zarubina IV, Shabanov PD. Cortexin and Cortagen as correcting agents in functional and metabolic disorders in the brain in chronic ischemia. Eksp Klin Farmakol. 2011;74(2):8-15.

Compliance Statement

This product is intended for laboratory research use only and is not approved for human or veterinary use.